Orbimed Advisors LLC, Director at Sionna Therapeutics, Inc. (SION), sold 202,656 shares at $44.54 ($9.0M) on 2025-11-24, disclosed to the SEC on 2025-11-26.
Open-market sale of $9.0M SION by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.54 | 94,583 | $4.2M | 46.7% |
| 2 | $44.54 | 94,583 | $4.2M | 46.7% |
| 3 | $44.60 | 11,890 | $530K | 5.9% |
| 4 | $44.49 | 1,600 | $71K | 0.8% |
| Total | $44.54 avg | 202,656 | $9.0M | 100% |
| Filing → |
| BRVE | BUY | 2026-08-11 | $34.9M | — | Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| SION | SELL | 2026-07-09 | $3.9M | — | Filing → |